United Kingdom

People: Avadel Pharmaceuticals PLC (AVDL.OQ)

AVDL.OQ on NASDAQ Stock Exchange Global Market

9:00pm BST
Change (% chg)

$-0.07 (-3.03%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kanan, Michael 

Mr. Michael F. Kanan serves as Senior Vice President, Chief Financial Officer of the Company since October 2015. Prior to joining Avadel, Mr. Kanan was employed by Sigma-Aldrich Corp. from April 2009 until November 2015, where he served as Vice President Finance, Corporate Controller and Chief Accounting Officer of Sigma-Aldrich from April 2009 until November 2015. Sigma-Aldrich is a life science and high technology company which was acquired by Merck KGaA, a health care, life science and performance materials company based in Germany, in November 2015. Mr. Kanan began his career at the international accounting firm Deloitte & Touche, and also held accounting and finance leadership positions with Hutchinson Group, a subsidiary of Total S.A., and Meritor, a global supplier of drivetrain, mobility, braking and aftermarket solutions for commercial vehicle and industrial markets. Mr. Kanan holds a Bachelor of Arts degree in Accounting from Michigan State University and became a CPA in 1987.

Basic Compensation

Total Annual Compensation, USD 1,041,750
Restricted Stock Award, USD 187,200
Long-Term Incentive Plans, USD --
All Other, USD 22,600
Fiscal Year Total, USD 1,251,550

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --